These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 10072114

  • 21. Common variable immunodeficiency presenting with persistent parvovirus B19 infection.
    Adams ST, Schmidt KM, Cost KM, Marshall GS.
    Pediatrics; 2012 Dec; 130(6):e1711-5. PubMed ID: 23129076
    [Abstract] [Full Text] [Related]

  • 22. Management of persistent B19 parvovirus infection in AIDS.
    Ramratnam B, Gollerkeri A, Schiffman FJ, Rintels P, Flanigan TP.
    Br J Haematol; 1995 Sep; 91(1):90-2. PubMed ID: 7577659
    [Abstract] [Full Text] [Related]

  • 23. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
    Kaya B, Paydas S.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
    [Abstract] [Full Text] [Related]

  • 24. Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intravenous immunoglobulin.
    Karmochkine M, Oksenhendler E, Leruez-Ville M, Jaccard A, Morinet F, Herson S.
    Am J Hematol; 1995 Nov; 50(3):227-8. PubMed ID: 7485092
    [No Abstract] [Full Text] [Related]

  • 25. A Case Report of Parvovirus B19 Infection in a Renal Allograft.
    Oramas DM, Setty S, Yeldandi V, Cabrera J, Patel T.
    Int J Surg Pathol; 2017 Oct; 25(7):648-651. PubMed ID: 28573901
    [Abstract] [Full Text] [Related]

  • 26. Successful Treatment of Anemia With Anaplastic and Microangiopathic Characteristics in a Kidney Transplant Recipient With Parvovirus B19 Infection: A Case Report.
    Mascia G, Argiolas D, Carta E, Ibba S, Piredda GB.
    Transplant Proc; 2020 Jun; 52(5):1619-1622. PubMed ID: 32389489
    [Abstract] [Full Text] [Related]

  • 27. Parvovirus B19 infection after plasma exchange for myasthenia gravis.
    Bianchi M, Rago I, Zini G, D'Onofrio G, Leone G.
    Lab Hematol; 2007 Jun; 13(1):34-8. PubMed ID: 17353182
    [Abstract] [Full Text] [Related]

  • 28. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?
    Finkel TH, Török TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR.
    Lancet; 1994 May 21; 343(8908):1255-8. PubMed ID: 7910276
    [Abstract] [Full Text] [Related]

  • 29. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T.
    Kansenshogaku Zasshi; 1995 May 21; 69(5):546-52. PubMed ID: 7602188
    [Abstract] [Full Text] [Related]

  • 30. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy.
    Alves MT, Vilaça SS, Godoi LC, Rezende Júnior L, Carvalho Md, Silva Fde S, Guimarães FL, Fernandes AP, Dusse LM, Gomes KB.
    Clin Chim Acta; 2014 Apr 20; 431():52-7. PubMed ID: 24513539
    [Abstract] [Full Text] [Related]

  • 31. [Human parvovirus B19-induced aplastic crisis in an elderly man with intestinal hemorrhage].
    Kamoshita M, Ohtani K, Hasegawa Y, Satoh Y, Kozima H, Shibuya A, Ninomiya H, Nagasawa T, Matsunaga Y, Abe T.
    Rinsho Ketsueki; 1993 Apr 20; 34(4):493-5. PubMed ID: 8510339
    [Abstract] [Full Text] [Related]

  • 32. Recurrent erythema in patients with long-term parvovirus B19 infection.
    Musiani M, Manaresi E, Gallinella G, Cricca M, Zerbini M.
    Clin Infect Dis; 2005 Jun 15; 40(12):e117-9. PubMed ID: 15909254
    [Abstract] [Full Text] [Related]

  • 33. Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS.
    Setúbal S, Jorge-Pereira MC, de Sant'Anna AL, de Oliveira SA, Bazin AR, do Nascimento JP.
    Rev Soc Bras Med Trop; 2003 Jun 15; 36(2):299-302. PubMed ID: 12806467
    [Abstract] [Full Text] [Related]

  • 34. Acute respiratory distress syndrome in a child with human parvovirus B19 infection.
    Ferraz C, Cunha F, Mota TC, Carvalho JM, Simões JS, Aparicio JM.
    Pediatr Infect Dis J; 2005 Nov 15; 24(11):1009-10. PubMed ID: 16282940
    [Abstract] [Full Text] [Related]

  • 35. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M, Juchler A, Flaviano A, Kaeppeli F.
    Gynecol Obstet Invest; 2007 Nov 15; 63(1):53-4. PubMed ID: 16940737
    [Abstract] [Full Text] [Related]

  • 36. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period.
    Rao SP, Miller ST, Cohen BJ.
    Am J Dis Child; 1992 Nov 15; 146(11):1328-30. PubMed ID: 1415073
    [Abstract] [Full Text] [Related]

  • 37. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
    Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS.
    N Engl J Med; 1994 Apr 28; 330(17):1192-6. PubMed ID: 8139629
    [Abstract] [Full Text] [Related]

  • 38. Parvovirus infection and its treatment.
    Young NS.
    Clin Exp Immunol; 1996 May 28; 104 Suppl 1():26-30. PubMed ID: 8625539
    [Abstract] [Full Text] [Related]

  • 39. Intrauterine anemia due to parvovirus B19: successful treatment with intravenous immunoglobulins.
    Rugolotto S, Padovani EM, Sanna A, Chiaffoni GP, Marradi PL, Borgna-Pignatti C.
    Haematologica; 1999 Jul 28; 84(7):668-9. PubMed ID: 10406919
    [No Abstract] [Full Text] [Related]

  • 40. [Human Parvovirus B19 infection and aplastic crisis].
    Pedersen G, Hansen JB, Jensen S.
    Ugeskr Laeger; 1993 Nov 29; 155(48):3897-900. PubMed ID: 8273192
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.